Displaying drugs 10001 - 10025 of 12494 in total
Creatinine
Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.
Investigational
Matched Description: … Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis. …
Kaempherol
Experimental
CRA_9076
Experimental
Banoxantrone
Banoxantrone is a highly selective bioreductive drug that is activated in, and is preferentially toxic to, hypoxic cells in tumours. It has been shown to work synergistically with fractionated radiation to significantly delay growth of tumours compared to administration of either banoxantrone or radiation alone. Banoxantrone was also efficacious in...
Investigational
Matched Description: … tumours compared to administration of either banoxantrone or radiation alone. ... It has been shown to work synergistically with fractionated radiation to significantly delay growth of …
AZD-3839
AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.
Investigational
Matched Description: … AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease …
Modimelanotide
Modimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery).
Investigational
Matched Iupac: … hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]butanoic acid …
Matched Description: … Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk ... Modimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple …
Matched Description: … Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk ... Modimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple …
A-98881
Experimental
Nimustine
Nimustine has been used in trials studying the treatment of Glioblastoma.
Investigational
Matched Description: … Nimustine has been used in trials studying the treatment of Glioblastoma. …
Oxantel
Experimental
CRA_10762
Experimental
CRA_10656
Experimental
Cirazoline
Cirazoline acts on a number of α adrenergic receptors. It is an agonist of α1A, partial agonist of α1B and α1D, and a nonselective antagonist of α2. It is believed that this combination of properties could make cirazoline an effective vasoconstricting agent.
Cirazoline has also been shown to decrease food...
Experimental
Matched Description: … It is an agonist of α1A, partial agonist of α1B and α1D, and a nonselective antagonist of α2. ... Cirazoline acts on a number of α adrenergic receptors. ... adrenoceptors in the paraventricular nucleus in the hypothalamus of the brain. …
Metralindole
Metralindole, also known as Inkazan, is similar in structure and pharmacology to pirlindole. It functions as a reversible inhibitor of monoamine oxidase A. In Russia, this drug was investigated for potential antidepressant activity.
Experimental
Matched Description: … It functions as a reversible inhibitor of monoamine oxidase A. …
Fenoxazoline
Experimental
Naringenin
Experimental
Pevonedistat
Pevonedistat has been used in trials studying the treatment of Lymphoma, Solid Tumors, Multiple Myeloma, Hodgkin Lymphoma, and Metastatic Melanoma, among others.
Investigational
Matched Description: … Pevonedistat has been used in trials studying the treatment of Lymphoma, Solid Tumors, Multiple Myeloma …
Displaying drugs 10001 - 10025 of 12494 in total